Starling Oncology, Inc. (STLN)
6.71
-0.20
(-2.89%)
USD |
NASDAQ |
Oct 23, 16:00
6.705
0.00 (0.00%)
After-Hours: 20:00
Starling Oncology Enterprise Value : 737.53M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 737.53M |
| October 22, 2026 | 757.62M |
| October 21, 2026 | 749.59M |
| October 20, 2026 | 729.49M |
| October 19, 2026 | 712.41M |
| October 16, 2026 | 709.40M |
| October 15, 2026 | 757.62M |
| October 14, 2026 | 717.44M |
| October 13, 2026 | 736.52M |
| October 12, 2026 | 758.63M |
| October 09, 2026 | 729.49M |
| October 08, 2026 | 684.28M |
| October 07, 2026 | 709.40M |
| October 06, 2026 | 724.47M |
| October 05, 2026 | 696.34M |
| October 02, 2026 | 701.36M |
| October 01, 2026 | 687.80M |
| September 30, 2026 | 698.35M |
| September 29, 2026 | 717.44M |
| September 28, 2026 | 730.50M |
| September 25, 2026 | 732.51M |
| September 24, 2026 | 717.44M |
| September 23, 2026 | 748.58M |
| September 22, 2026 | 771.69M |
| September 21, 2026 | 749.59M |
| Date | Value |
|---|---|
| September 18, 2026 | 762.65M |
| September 17, 2026 | 729.49M |
| September 16, 2026 | 719.44M |
| September 15, 2026 | 703.37M |
| September 14, 2026 | 718.44M |
| September 11, 2026 | 683.28M |
| September 10, 2026 | 686.29M |
| September 09, 2026 | 695.33M |
| September 08, 2026 | 698.35M |
| September 04, 2026 | 659.16M |
| September 03, 2026 | 663.18M |
| September 02, 2026 | 675.24M |
| September 01, 2026 | 660.17M |
| August 31, 2026 | 657.15M |
| August 28, 2026 | 683.28M |
| August 27, 2026 | 700.36M |
| August 26, 2026 | 722.46M |
| August 25, 2026 | 696.34M |
| August 24, 2026 | 679.26M |
| August 21, 2026 | 712.91M |
| August 20, 2026 | 720.45M |
| August 19, 2026 | 732.51M |
| August 18, 2026 | 706.38M |
| August 17, 2026 | 697.34M |
| August 14, 2026 | 711.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.189B |
| Agilon Health, Inc. | 1.282B |
| Nakamoto, Inc. | 277.34M |
| American Oncology Network, Inc. | -- |
| Regional Health Properties, Inc. | 61.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.241M |
| Revenue (Quarterly) | 161.28M |
| Total Expenses (Quarterly) | 169.52M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 15.70% |
| Profit Margin (Quarterly) | -5.11% |
| Earnings Yield | -4.55% |
| Normalized Earnings Yield | -4.203 |